Effect of sodium valproate administration on brain neprilysin expression and memory in rats

Journal of Molecular Neuroscience

Volumn 46, Issue 3, 2012, Pages 569-577

  Nalivaeva, Natalia N ^a,b   Belyaev, Nikolai D ^a   Lewis, David I ^a   Pickles, Alasdair R ^a   Makova, Natalia Z ^a   Bagrova, Daria I ^b   Dubrovskaya, Nadezhda M ^b   Plesneva, Svetlana A ^b   Zhuravin, Igor A ^b   Turner, Anthony J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

Author keywords

AICD; Alzheimer's disease; Amyloid precursor protein (APP); Cortex; Hippocampus; Histone deacetylase (HDAC); Memory; Neprilysin; Novel object recognition test; Prenatal hypoxia; Valproic acid

Indexed keywords

AMYLOID PRECURSOR PROTEIN; HISTONE DEACETYLASE; MEMBRANE METALLOENDOPEPTIDASE; VALPROIC ACID;

AGED; ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; COGNITION; CONTROLLED STUDY; GENE EXPRESSION; HIPPOCAMPUS; HYPOXIA; LONG TERM MEMORY; MALE; MEMORY; NONHUMAN; PROTEIN EXPRESSION; RAT; SHORT TERM MEMORY; UPREGULATION;

ALZHEIMER DISEASE; ANIMALS; ANTICONVULSANTS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MEMORY; MEMORY DISORDERS; NEPRILYSIN; NEUROBLASTOMA; RATS; RATS, WISTAR; VALPROIC ACID;

RATTUS;

EID: 84859148674     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-011-9644-x     Document Type: Article

References (55)

1. Alves da Costa C, Sunyach C, Pardossi-Piquard R et al (2006) Presenilin-dependent γ-secretase-mediated control of p53-associated cell death in Alzheimer's disease. J Neurosci 26:6377-6385
2. Anderova M, Vorisek I, Pivonkova H et al (2011) Cell death/proliferation and alterations in glial morphology contribute to changes in diffusivity in the rat hippocampus after hypoxiaischemia. J Cereb Blood Flow Metab 31:894-907
3. Aydin D, Filippov MA, Tschäpe JA et al (2011) Comparative transcriptome profiling of amyloid precursor protein family members in the adult cortex. BMC Genomics 12:160
4. Barnes K, Turner AJ, Kenny AJ (1992) Membrane localization of endopeptidase-24.11 and peptidyl dipeptidase A (angiotensin converting enzyme) in the pig brain: a study using subcellular fractionation and electron microscopic immunocytochemistry. J Neurochem 58:2088-2096
5. Belyaev ND, Kellett KA, Beckett C et al (2010) The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a β-secretase-dependent pathway. J Biol Chem 285:41443-41454
6. Belyaev ND, Nalivaeva NN, Makova NZ et al (2009) Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer's disease. EMBO Rep 10:94-100
7. Caccamo A, Oddo S, Sugarman MC et al (2005) Age- and region-dependent alterations in Aβ-degrading enzymes: implications for Aβ-induced disorders. Neurobiol Aging 26:645-654 (Pubitemid 40228756)
8. Cao X, Südhof TC (2004) Dissection of amyloid-β precursor protein-dependent transcriptional transactivation. J Biol Chem 279:24601-24611 (Pubitemid 38725327)
9. Carson JA, Turner AJ (2002) Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases? J Neurochem 81:1-8 (Pubitemid 34808849)
10. Chen AC, Selkoe DJ (2007) Response to: Pardossi-Piquard et al., "Presenilin-dependent transcriptional control of the Aβ-degrading enzyme neprilysin by intracellular domains of βAPP and APLP." Neuron 46:541-554,
11. 53: 479-483
12. Dubrovskaya NM, Nalivaeva NN, Plesneva SA et al (2009) Changes inthe activity of amyloid-degrading metallopeptidases leads to disruption of memory in rats. Zh Vyssh Nerv Deiat Im I P Pavlova 59:630-638
13. Dubrovskaya NM, Nalivaeva NN, Turner AJ et al (2006) Effects of an inhibitor of α-secretase, which metabolizes the amyloid peptide precursor, on memory formation in rats. Neurosci Behav Physiol 36:911-913 (Pubitemid 44524013)
14. Dubrovskaya NM, Zhuravin IA (2010) Ontogenetic characteristics of behavior in rats subjected to hypoxia on day 14 or day 18 of embryogenesis. Neurosci Behav Physiol 40:231-238
15. Ennaceur A, Delacour J (1988) A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behav Brain Res 31:47-59
16. Erdos EG, Skidgel RA (1989) Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J 3:145-151
17. Fischer A, Sananbenesi F, Wang X et al (2007) Recovery of learning and memory is associated with chromatin remodelling. Nature 447:178-182 (Pubitemid 46763080)
18. Fischer A, Sananbenesi F, Mungenast A et al (2010) Targeting the correct HDAC(s) to treat cognitive disorders. Trends Pharmacol Sci 31:605-617
19. Fisk L, Nalivaeva NN, Boyle JP et al (2007) Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes. Neurochem Res 32:1741-1748 (Pubitemid 47428855)
20. Fulcher IS, Matsas R, Turner AJ et al (1982) Kidney neutral endopeptidase and the hydrolysis of enkephalin by synaptic membranes show similar sensitivity to inhibitors. Biochem J 203:519-522 (Pubitemid 12127735)
21. Hama E, Saido TC (2005) Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide. Med Hypotheses 65:498-500 (Pubitemid 40956947)
22. Hardy J (2009) The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J Neurochem 110:1129-1134
23. Hardy JA, Higgins GA (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256:184-185
24. Hébert SS, Serneels L, Tolia A et al (2006) Regulated intramembrane proteolysis of amyloid precursor protein and regulation of expression of putative target genes. EMBO Rep 7:739-745 (Pubitemid 43986273)
25. Hong Y, Beckett C, Belyaev ND et al (2011) The impact of amyloid precursor protein signalling and histone deacetylase inhibition on neprilysin expression in human prostate cells. Int J Cancer. doi:10.1002/ijc.26028. [Epub ahead of print]
26. 1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 6:143-150
27. Kim HJ, Bae SC (2011) Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am J Transl Res 3:166-179
28. Kimberly WT, Zheng JB, Guénette SY et al (2001) The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner. J Biol Chem 276:40288-40292
29. KonietzkoU (2011) AICDNuclear signaling and its possible contribution to Alzheimer's disease. Curr Alzheimer Res (in press)
30. Lazarov O, Robinson J, Tang YP et al (2005) Environmental enrichment reduces Aβ levels and amyloid deposition in transgenic mice. Cell 120:701-713 (Pubitemid 40343081)
31. Lefranc-Jullien S, Sunyach C, Checler F (2006) APPε, the ε- secretase-derived N-terminal product of the β-amyloid precursor protein, behaves as a type I protein and undergoes α-, β-, and γ- secretase cleavages. J Neurochem 97:807-817
32. Liang K, Yang L, Yin C et al (2010) Estrogen stimulates degradation of β-amyloid peptide by up-regulating neprilysin. J Biol Chem 285:935-942
33. Matsas R, Kenny AJ, Turner AJ (1986) An immunohistochemical study of endopeptidase-24.11 ("enkephalinase") in the pig nervous system. Neuroscience 18:991-1012 (Pubitemid 16074939)
34. Mawuenyega KG, Sigurdson W, Ovod V et al (2010) Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science 330:1774
35. Mello PB, Benetti F, Cammarota M et al (2008) Effects of acute and chronic physical exercise and stress on different types of memory in rats. An Acad Bras Cienc 80:301-309 (Pubitemid 351798946)
36. Monti B, Polazzi E, Contestabile A (2009) Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. Curr Mol Pharmacol 2:95-109
37. Nalivaeva NN, Belyaev ND, Turner AJ (2009) Sodium valproate: an old drug with new roles. Trends Pharmacol Sci 30:509-514
38. Nalivaeva NN, Fisk L, Kochkina EG et al (2004) Effect of hypoxia/ischemia and hypoxic preconditioning/reperfusion on expression of some amyloid-degrading enzymes. Ann N YAcad Sci 1035:21-33 (Pubitemid 40362324)
39. Nalivaeva NN, Fisk LR, Belyaev ND et al (2008) Amyloid-degrading enzymes astherapeutic targets in Alzheimer's disease. Curr Alzheimer Res 5:212-224 (Pubitemid 351536346)
40. Pardossi-Piquard R, Petit A, Kawarai T et al (2005) Presenilin-dependent transcriptional control of the Aβ-degrading enzyme neprilysin by intracellular domains of βAPP and APLP. Neuron 46:541-554 (Pubitemid 40797380)
41. Qian YR, Lee MJ, Hwang S et al (2010) Neuroprotection by valproic acid in mouse models of permanent and transient focal cerebral ischemia. Korean J Physiol Pharmacol 14:435-440
42. Qing H, He G, Ly PT et al (2008) Valproic acid inhibits Aßproduction, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models. J Exp Med 205:2781-2789
43. Saito T, Iwata N, Tsubuki S et al (2005) Somatostatin regulates brain amyloid β peptide Aβ42 through modulation of proteolytic degradation. Nat Med 11:434-439 (Pubitemid 40562335)
44. Schettini G, Govoni S, Racchi M et al (2010) Phosphorylation of APP-CTF-AICD domains and interaction with adaptor proteins: signal transduction and/or transcriptional role-relevance for Alzheimer pathology. J Neurochem 115:1299-1308
45. Tremolizzo L, Carboni G, Ruzicka WB et al (2002) An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc Natl Acad Sci USA 99:17095-17100 (Pubitemid 36034104)
46. Turner AJ, Belyaev ND, Nalivaeva NN (2011) Mediator: the missing link in amyloid precursor protein nuclear signalling. EMBO Rep 12:180-181
47. Venkataramani V, Rossner C, Iffland L et al (2010) Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via downregulation of the Alzheimer amyloid precursor protein. J Biol Chem 285:10678-10689
48. Walsh DM, Klyubin I, Fadeeva JV et al (2002) Naturally secreted oligomers ofamyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535-539 (Pubitemid 34288854)
49. Wang S, Wang R, Chen L et al (2010) Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain. J Neurochem 115:47-57
50. Wang Z, Yang D, Zhang X et al (2011a) Hypoxia-induced downregulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons. PLoS One 6(4):e19229
51. Wang Z, Leng Y, Tsai LK et al (2011b) Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J Cereb Blood Flow Metab 31:52-57
52. Weller RO, Subash M, Preston SD et al (2008) Perivascular drainage of amyloid-β peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol 18:253-266 (Pubitemid 351430402)
53. Xu X, Zhou H, Boyer TG (2011) Mediator is atransducer of amyloid-precursor-protein-dependent nuclear signalling. EMBO Rep 12:216-222
54. Yildirim E, Zhang Z, Uz T et al (2003) Valproate administration tomice increases histone acetylation and 5-lipoxygenase content in the hippocampus. Neurosci Lett 345:141-143 (Pubitemid 36734881)
55. Zhang XZ, Li XJ, Zhang HY (2010) Valproic acid as apromising agent to combat Alzheimer's disease. Brain Res Bull 81:3-6